Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 5/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | PRKCA | P17252 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18133301 | 0.90 | EPHX2 (0.35) | CYP17A1CYP19A1EPHX2PRKCATSHR | |
| SCHEMBL23559488 | 0.90 | EPHX2 (0.35) | CYP17A1CYP19A1EPHX2PRKCATSHR | |
| SCHEMBL6448541 | 0.90 | EPHX2 (0.35) | CYP17A1CYP19A1EPHX2PRKCATSHR | |
| SCHEMBL26190788 | 0.89 | PRKCA (0.40) | CYP17A1CYP19A1PRKCATSHRNPSR1 | |
| SCHEMBL26190682 | 0.88 | CYP17A1 (0.34) | CYP17A1CYP19A1EPHX2PRKCATSHR | |
| SCHEMBL19042387 | 0.88 | EPHX2 (0.33) | CYP17A1CYP19A1EPHX2PRKCATSHR | |
| SCHEMBL22797667 | 0.87 | EPHX2 (0.33) | CYP17A1CYP19A1EPHX2PRKCATSHR | |
| SCHEMBL13642226 | 0.85 | CYP17A1 (0.38) | CYP17A1CYP19A1EPHX2PRKCATSHR | |
| SCHEMBL2130379 | 0.85 | CYP17A1 (0.32) | CYP17A1CYP19A1PRKCATSHRNPSR1 | |
| SCHEMBL14554295 | 0.81 | EPHX2 (0.35) | CYP17A1CYP19A1EPHX2PRKCATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230341772-A1 | RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING RESIST PATTERN | JSR CORPORATION (JP) | 2023-10-26 | — | — | US | disclosed |
| US-11747725-B2 | Radiation-sensitive resin composition and method for forming resist pattern | JSR CORPORATION (JP) | 2023-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230341772-A1 | RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING RESIST PATTERN | RER1, XRCC5, F12 | CYP17A1 2352/4885CYP19A1 2673/4885EPHX2 655/4885 |
| US-11747725-B2 | Radiation-sensitive resin composition and method for forming resist pattern | RER1, AFF1, RAD51 | CYP17A1 2648/4885CYP19A1 1731/4885EPHX2 430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.